Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products

被引:43
|
作者
Bousses, Christine [1 ]
Ferey, Ludivine [2 ]
Vedrines, Elodie [1 ]
Gaudin, Karen [2 ]
机构
[1] Unither Developpement, Analyt Innovat, F-33185 Le Haillan, France
[2] Bordeaux Univ, EA Analyt & Pharmaceut Dev Appl Neglected Dis & C, F-33076 Bordeaux, France
关键词
Quality-by-design; Green chemistry; Experimental designs; Robustness; Accuracy profile; Dextromethorphan; ENVIRONMENTAL ASSESSMENT; CHROMATOGRAPHY; PRINCIPLES; DEXTROMETHORPHAN; PSEUDOEPHEDRINE; ELECTROPHORESIS; PARACETAMOL; SEPARATION; OPTIMIZE;
D O I
10.1016/j.jpba.2015.07.003
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
An innovative combination of green chemistry and quality by design (QbD) approach is presented through the development of an UHPLC method for the analysis of the main degradation products of dextromethorphan hydrobromide. QbD strategy was integrated to the field of green analytical chemistry to improve method understanding while assuring quality and minimizing environmental impacts, and analyst exposure. This analytical method was thoroughly evaluated by applying risk assessment and multivariate analysis tools. After a scouting phase aimed at selecting a suitable stationary phase and an organic solvent in accordance with green chemistry principles, quality risk assessment tools were applied to determine the critical process parameters (CPPs). The effects of the CPPs on critical quality attributes (CQAs), i.e., resolutions, efficiencies, and solvent consumption were further evaluated by means of a screening design. A response surface methodology was then carried out to model CQAs as function of the selected CPPs and the optimal separation conditions were determined through a desirability analysis. Resulting contour plots enabled to establish the design space (DS) (method operable design region) where all CQAs fulfilled the requirements. An experimental validation of the DS proved that quality within the DS was guaranteed; therefore no more robustness study was required before the validation. Finally, this UHPLC method was validated using the concept of total error and was used to analyze a pharmaceutical drug product. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 50 条
  • [21] Rapid UHPLC Method Development for Omeprazole Analysis in a Quality-by-Design Framework and Transfer to HPLC Using Chromatographic Modeling
    Schmidt, Alexander H.
    Stanic, Mijo
    LCGC NORTH AMERICA, 2014, 32 (02) : 126 - 148
  • [22] An Application of Quality by Design and Analytical Greenness Assessment Approach for the Development of Erlotinib Stability Indicating Method
    Satyam Gundecha
    Mital Patel
    Y. C. Mayur
    Chromatographia, 2022, 85 : 575 - 588
  • [23] An Application of Quality by Design and Analytical Greenness Assessment Approach for the Development of Erlotinib Stability Indicating Method
    Gundecha, Satyam
    Patel, Mital
    Mayur, Y. C.
    CHROMATOGRAPHIA, 2022, 85 (07) : 575 - 588
  • [24] Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: A case of a learning process
    Hubert, C.
    Lebrun, P.
    Houari, S.
    Ziemons, E.
    Rozet, E.
    Hubert, Ph.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 88 : 401 - 409
  • [25] Stability-Indicating Analytical Method Development Using Quality by Design (QbD) Approach for Simultaneous Estimation of Budesonide and Levosalbutamol
    Gandhi, Noopur
    Ezhava, Sindhu
    JOURNAL OF AOAC INTERNATIONAL, 2022, 105 (03) : 665 - 674
  • [26] Integrating green analytical chemistry and analytical quality by design: an innovative approach for RP-UPLC method development of ensifentrine in bulk and inhalation formulations
    Mohan Goud Vanga
    Sarad Pawar Naik Bukke
    Praveen Kumar Kusuma
    Bayapa Reddy Narapureddy
    Chandrashekar Thalluri
    BMC Chemistry, 19 (1)
  • [27] Stability-indicating reversed-phase-HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality-by-design approach
    Subramanian, Velusamy B.
    Katari, Naresh Kumar
    Ponnam, Vijetha
    Konduru, Naresh
    Dongala, Thirupathi
    Marisetti, Vishnu M.
    Vyas, Govind
    BIOMEDICAL CHROMATOGRAPHY, 2022, 36 (01)
  • [28] Circular Economy and Green Chemistry: The Need for Radical Innovative Approaches in the Design for New Products
    Ncube, Amos
    Mtetwa, Sandile
    Bukhari, Mahak
    Fiorentino, Gabriella
    Passaro, Renato
    ENERGIES, 2023, 16 (04)
  • [29] Review Experiences and Regulatory Challenges for Pharmaceutical Development in Japan Using a Quality-by-Design Approach
    Kuno, Kiyohito
    Toyoshima, Satoshi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2016, 50 (03) : 368 - 374
  • [30] Review Experiences and Regulatory Challenges for Pharmaceutical Development in Japan Using a Quality-by-Design Approach
    Kiyohito Kuno
    Satoshi Toyoshima
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 368 - 374